A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis trea...

par Cohen, S, Moreland, L, Cush, J, Greenwald, M, Block, S, Shergy, W, Hanrahan, P, Kraishi, M, Patel, A, Sun, G, Bear, M
Publié 2004

Racial or ethnic differences in allele frequencies of single‐nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexat...

par Hughes, L B, Beasley, T M, Patel, H, Tiwari, H K, Morgan, S L, Baggott, J E, Saag, K G, McNicholl, J, Moreland, L W, Alarcón, G S, Bridges, S L
Publié 2006

Access to disease modifying treatments for rheumatoid arthritis patients

par FURST, D, BREEDVELD, F, BURMESTER, G, CROFFORD, L, EMERY, P, FELDMAN, M, KALDEN, J, KAVANAUGH, A, KEYSTONE, E, LIPSKY, P, MAINI, R, MORELAND, L, SMOLEN, J, VAN DE PUTTE, L, VISCHER, T, WEINBLATT, M, WEISSMAN, M
Publié 1999

Minimally important difference in diffuse systemic sclerosis: results from the d‐penicillamine study

par Khanna, D, Furst, D E, Hays, R D, Park, G S, Wong, W K, Seibold, J R, Mayes, M D, White, B, Wigley, F F, Weisman, M, Barr, W, Moreland, L, Medsger, T A, Steen, V D, Martin, R W, Collier, D, Weinstein, A, Lally, E V, Varga, J, Weiner, S R, Andrews, B, Abeles, M, Clements, P J
Publié 2006

The Use of Phenome-Wide Association Studies (PheWAS) for Exploration of Novel Genotype-Phenotype Relationships and Pleiotropy Discovery

par Pendergrass, S.A., Brown-Gentry, K., Dudek, S.M., Torstenson, E.S., Ambite, J.L., Avery, C.L., Buyske, S., Cai, C., Fesinmeyer, M.D., Haiman, C., Heiss, G., Hindorff, L.A., Hsu, C.-N., Jackson, R.D., Kooperberg, C., Le Marchand, L., Lin, Y., Matise, T.C., Moreland, L., Monroe, K., Reiner, A.P., Wallace, R., Wilkens, L.R., Crawford, D.C., Ritchie, M.D.
Publié 2011